Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.
Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H.
Matsumoto A, et al. Among authors: nishiguchi s.
Hepatol Res. 2012 Feb;42(2):139-49. doi: 10.1111/j.1872-034X.2011.00910.x. Epub 2011 Nov 22.
Hepatol Res. 2012.
PMID: 22103237